Illustration of a child with “werewolf” syndrome. Photo: AFP/Getty Images Pictured is Lalit Patidar, a 13-year-old boy with Iпdia "wer...
Pictured is Lalit Patidar, a 13-year-old boy with Iпdia "werewolf" syndrome. Photo: Barcroft Media
Some parents told Global News 10 that after discovering "hair growth in their children, especially on the face," they cried to see a doctor. Therefore, local authorities quickly identified the phenomenology of genetic diseases occurring in many families.
Spai's health and pharmaceutical agency ordered the withdrawal from the market of the first batch of potentially cotamipated mioxidil last month after receiving reports of 13 cases of "werewolf disease", with a further three cases reported. previously discovered this moth. Authorities said the cotamipated drugs with myoxidil may have affected 30 pharmacies and more than 50 batches of drugs.
The pharmaceutical company Farma-Qυímica Sυr has reportedly purchased the drug omeprazole cotamipato from Idia and distributed it on the Spanish market. Indeed, this company has had its license suspended and is not allowed to produce or import it. Or even distribute drugs.
Hypertrichosis, also known as Ambras syndrome or “werewolf disease,” is a genetic disorder that causes beard, hair, and body hair to grow abnormally. This syndrome is very rare with a probability of approximately 1/1,000,000 people. Even if the patient may not suffer from physical suffering, he will have to endure social discrimination because of his normal appearance.
Indeed, medical experts are still unable to find a complete cure for this disease. The best way to help patients become more integrated into the community is to shave or wax regularly.
COMMENTS